Clinical Trial: Cyproheptadine as an Appetite Stimulant

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Effect of Cyproheptadine on Weight Gain and Feeding Behavior in 2 to 4 Years Old Children With Failure to Thrive

Brief Summary: Cyproheptadine is currently clinically used as an appetite stimulant for children with failure to thrive without underlying organic disease. Otherwise, no randomised control trial demonstrates the efficacy of Cyproheptadine on those patients. This is precisely what the investigators intend to demonstrate on this randomised placebo control cross-over trial. Our hypothesis is that Cyproheptadine is more efficient than placebo to improve weight gain and feeding behaviour on 2 to 4 years old children with failure to thrive.

Detailed Summary:
Sponsor: St. Justine's Hospital

Current Primary Outcome: Weight gain [ Time Frame: January 2011 to January 2012 ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Feeding behaviour [ Time Frame: January 2011 to January 2012 ]

Original Secondary Outcome: Same as current

Information By: St. Justine's Hospital

Dates:
Date Received: March 14, 2011
Date Started: December 2010
Date Completion: January 2012
Last Updated: March 14, 2011
Last Verified: March 2011